United States Therapeutic Plasma Exchange Sales Market Report 2021

United States Therapeutic Plasma Exchange Sales Market Report 2021

1 Therapeutic Plasma Exchange Overview

1.1 Product Overview and Scope of Therapeutic Plasma Exchange

1.2 Classification of Therapeutic Plasma Exchange

1.2.1 Neurological

1.2.2 Autoimmune Disorder

1.2.3 Type III

1.3 Applications of Therapeutic Plasma Exchange

1.3.1 Guillain Barre Syndrome

1.3.2 Multiple Sclerosis

1.3.3 Myasthenia Gravis

1.3.4 Thrombotic Thrombocytopenic Purpura

1.3.5 Glomerulonephritis

1.4 USA Market Size (Value and Volume) of Therapeutic Plasma Exchange (2011-2021)

1.4.1 USA Therapeutic Plasma Exchange Sales, Revenue and Price (2011-2021)

1.4.2 USA Therapeutic Plasma Exchange Sales and Growth Rate (2011-2021)

1.4.3 USA Therapeutic Plasma Exchange Revenue and Growth Rate (2011-2021)

2 USA Therapeutic Plasma Exchange Competition by Manufacturers

2.1 USA Therapeutic Plasma Exchange Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Therapeutic Plasma Exchange Revenue and Share by Manufactures (2015 and 2016)

3 USA Therapeutic Plasma Exchange (Volume and Value) by Type

3.1 USA Therapeutic Plasma Exchange Sales and Market Share by Type (2011-2021)

3.2 USA Therapeutic Plasma Exchange Revenue and Market Share by Type (2011-2021)

4 USA Therapeutic Plasma Exchange (Volume) by Application

5 USA Therapeutic Plasma Exchange Manufacturers Analysis

5.1 Haemonetics Corporation

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Therapeutic Plasma Exchange Product Type and Technology

5.1.2.1 Neurological

5.1.2.2 Autoimmune Disorder

5.1.3 Therapeutic Plasma Exchange Sales, Revenue, Price of Haemonetics Corporation (2015 and 2016)

5.2 Fresenius Medical

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Medical Devices Product Type and Technology

5.2.2.1 Neurological

5.2.2.2 Autoimmune Disorder

5.2.3 Medical Devices Sales, Revenue, Price of Fresenius Medical (2015 and 2016)

5.3 Terumo BCT, Inc.

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Terumo BCT, Inc. Product Type and Technology

5.3.2.1 Neurological

5.3.2.2 Autoimmune Disorder

5.3.3 Terumo BCT, Inc. Sales, Revenue, Price of Terumo BCT, Inc. (2015 and 2016)

5.4 Baxter International Inc.

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Product Type and Technology

5.4.2.1 Neurological

5.4.2.2 Autoimmune Disorder

5.4.3 Baxter International Inc. Sales, Revenue, Price of Baxter International Inc. (2015 and 2016)

5.5 Asahi Kasei Medical Co.

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Asahi Kasei Medical Co. Product Type and Technology

5.5.2.1 Neurological

5.5.2.2 Autoimmune Disorder

5.5.3 Asahi Kasei Medical Co. Sales, Revenue, Price of Asahi Kasei Medical Co. (2015 and 2016)

5.6 Kawasumi Laboratories Inc.

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Kawasumi Laboratories Inc. Product Type and Technology

5.6.2.1 Neurological

5.6.2.2 Autoimmune Disorder

5.6.3 Kawasumi Laboratories Inc. Sales, Revenue, Price of Kawasumi Laboratories Inc. (2015 and 2016)

5.7 B. Braun Melsungen AG

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 B. Braun Melsungen AG Product Type and Technology

5.7.2.1 Neurological

5.7.2.2 Autoimmune Disorder

5.7.3 B. Braun Melsungen AG Sales, Revenue, Price of B. Braun Melsungen AG (2015 and 2016)

5.8 HemaCare Corporation

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 HemaCare Corporation Product Type and Technology

5.8.2.1 Neurological

5.8.2.2 Autoimmune Disorder

5.8.3 HemaCare Corporation Sales, Revenue, Price of HemaCare Corporation (2015 and 2016)

6 Therapeutic Plasma Exchange Technology and Development Trend

6.1 Therapeutic Plasma Exchange Technology Analysis

6.2 Therapeutic Plasma Exchange Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Therapeutic Plasma Exchange

Table Classification of Therapeutic Plasma Exchange

Figure USA Sales Market Share of Therapeutic Plasma Exchange by Type in 2015

Figure Neurological Picture

Figure Autoimmune Disorder Picture

Table Applications of Therapeutic Plasma Exchange

Figure USA Sales Market Share of Therapeutic Plasma Exchange by Application in 2015

Figure Guillain Barre Syndrome Examples

Figure Multiple Sclerosis Examples

Figure Myasthenia Gravis Examples

Figure Thrombotic Thrombocytopenic Purpura Examples

Figure Glomerulonephritis Examples

Table USA Therapeutic Plasma Exchange Sales, Revenue and Price (2011-2021)

Figure USA Therapeutic Plasma Exchange Sales and Growth Rate (2011-2021)

Figure USA Therapeutic Plasma Exchange Revenue and Growth Rate (2011-2021)

Table USA Therapeutic Plasma Exchange Sales of Key Manufacturers (2015 and 2016)

Table USA Therapeutic Plasma Exchange Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Therapeutic Plasma Exchange Sales Share by Manufacturers

Figure 2016 Therapeutic Plasma Exchange Sales Share by Manufacturers

Table USA Therapeutic Plasma Exchange Revenue by Manufacturers (2015 and 2016)

Table USA Therapeutic Plasma Exchange Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Therapeutic Plasma Exchange Revenue Share by Manufacturers

Table 2016 USA Therapeutic Plasma Exchange Revenue Share by Manufacturers

Table USA Therapeutic Plasma Exchange Sales and Market Share by Type (2011-2021)

Table USA Therapeutic Plasma Exchange Sales Share by Type (2011-2021)

Figure Sales Market Share of Therapeutic Plasma Exchange by Type (2011-2021)

Figure USA Therapeutic Plasma Exchange Sales Growth Rate by Type (2011-2021)

Table USA Therapeutic Plasma Exchange Revenue and Market Share by Type (2011-2021)

Table USA Therapeutic Plasma Exchange Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Therapeutic Plasma Exchange by Type (2011-2021)

Figure USA Therapeutic Plasma Exchange Revenue Growth Rate by Type (2011-2021)

Table USA Therapeutic Plasma Exchange Sales and Market Share by Application (2011-2021)

Table USA Therapeutic Plasma Exchange Sales Share by Application (2011-2021)

Figure Sales Market Share of Therapeutic Plasma Exchange by Application (2011-2021)

Figure USA Therapeutic Plasma Exchange Sales Growth Rate by Application (2011-2021)

Table Haemonetics Corporation Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Haemonetics Corporation (2015 and 2016)

Table Fresenius Medical Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Fresenius Medical (2015 and 2016)

Table Terumo BCT, Inc. Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Terumo BCT, Inc. (2015 and 2016)

Table Baxter International Inc. Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Baxter International Inc. (2015 and 2016)

Table Asahi Kasei Medical Co. Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Asahi Kasei Medical Co. (2015 and 2016)

Table Kawasumi Laboratories Inc. Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of Kawasumi Laboratories Inc. (2015 and 2016)

Table B. Braun Melsungen AG Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of B. Braun Melsungen AG (2015 and 2016)

Table HemaCare Corporation Basic Information List

Table Therapeutic Plasma Exchange Sales, Revenue, Price of HemaCare Corporation (2015 and 2016)